For decades, J&J has helped address some of the world’s toughest health challenges and advance global health equity. At the core of this effort is enabling people to have access to affordable lifesaving and life-enhancing treatments in every corner of the world.
Across J&J, we embed strategies that advance access to care systems for patients. For instance, we apply our Innovative Medicine Access and Pricing Principles across our entire pharmaceutical portfolio, planning for access early in the research phase.
We address health equity gaps in resource-limited settings by leveraging established and novel mechanisms to enhance equitable access to quality care in a number of areas, including:
Advancing access to treatment for drug-resistant tuberculosis
Enabling quality surgical care by closing gaps in cleft conditions, obstetric fistula and long bone fracture care
Treating blindness through cataract surgery training
In parallel, we have applied our proven capabilities in R&D to advance innovation and deploy solutions across diseases such as Ebola, neglected tropical diseases and AMR.
